A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia
Phase of Trial: Phase I/II
Latest Information Update: 26 Jun 2015
At a glance
- Drugs Finasteride (Primary) ; Minoxidil
- Indications Alopecia
- Focus Proof of concept; Therapeutic Use
- Sponsors Dong-A ST
- 26 Jun 2015 Last checked against ClinicalTrials.gov record.
- 23 Jun 2015 Status changed from active, no longer recruiting to completed ClinicalTrials.gov record.
- 01 Dec 2014 Planned End Date changed from 1 Oct 2014 to 1 Jan 2015 ClinicalTrials.gov record.